Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/add.16742 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Why we need a representative organization of academic PRM in Europe, and why we need it now.
J Rehabil Med
January 2025
Department of Biomedical, Surgical, and Dental Sciences, University of Milan "La Statale", Milan, Italy; IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
The growing relevance of rehabilitation in healthcare to address increasing patient needs necessitates robust Physical and Rehabilitation Medicine (PRM) integration into medical education and practice. Academic PRM, rooted in medical faculties, is vital for developing the medical speciality as an academic discipline across Europe, where it faces challenges, including limited representation in medical schools and competition for resources with established disciplines. This commentary advocates establishing a representative organization for academic PRM in Europe.
View Article and Find Full Text PDFCommentary on Stam et al.: The substantial and dynamic contribution of opioid potency to total overdose risk.
Addiction
February 2025
Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA, USA.
SCUBE2, where are you? Recruitment of SCUBE2 to adherens junctions preserves vascular health and integrity.
Cardiovasc Res
November 2024
Institute of Biology, Leiden University, Gorleaus Building, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial.
JAMA Pediatr
June 2024
Department of Neuropediatrics and Muscle Disorders, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Article Synopsis
- Early diagnosis and treatment are crucial for improving outcomes in infants with spinal muscular atrophy (SMA), leading to the implementation of newborn screening programs, but there is a lack of robust data confirming their benefits.* -
- This study compared SMA patients diagnosed through newborn screening to those diagnosed after symptoms appeared, using data from 234 children across Germany, Austria, and Switzerland from the SMARTCARE registry.* -
- Results showed that infants identified through newborn screening started treatment significantly earlier (average 1.3 months) than those diagnosed by symptoms (average 10.7 months), leading to better motor milestones, such as higher rates of independent sitting and walking.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!